Influence of pro-algesic foods on chronic pain conditions

References

• Alpay K, Ertas M, Orhan EK, et al. Diet restriction in migraine, based on IgG against foods: A clinical double-blind, randomised, cross-over trial. Cephalalgia. 2010;30:829–837.
   PubMed Web of Science ®Google Scholar
• Peatfield RC. Relationships between food, wine, and beer-precipitated migrainous headaches. Headache. 1995;35:355–357.
   PubMed Web of Science ®Google Scholar
• Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.
   PubMed Web of Science ®Google Scholar
• Heath KM aEP. Vitamin D Deficiency: Implications in the Rehabilitation Setting. Am J Phys Med Rehabil. 2006;85:916–923.
   PubMed Web of Science ®Google Scholar
• Cairns BE, Gambarota G, Svensson P, et al. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience. 2002;109:389–399.
   PubMed Web of Science ®Google Scholar
• Freeman M. Reconsidering the effects of MSG. J Amer Acad Nurse Pract. 2006;18:482–486.
   PubMed Web of Science ®Google Scholar
• Geha RS, Beiser A, Ren C, et al. Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study. J Nutr. 2000;130(4S Suppl):58S–62S.
   Google Scholar
• Nelson LM, Matkin C, Longstreth WTJ, et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol. 2000;151:164–173.
   PubMed Web of Science ®Google Scholar
• Stegink LD, Filer LJJ, Baker GL. Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame. J Nutr. 1983;113:1851–1860.
   PubMed Web of Science ®Google Scholar
• Graham TE, Sgro V, Friars D, et al. Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans. Am J Physiol Endocrinol Metab. 2000;278:E83–E89.
   PubMed Web of Science ®Google Scholar
• Schaumburg HH, Byck R, Gerstl R, et al. Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science. 1969;163:826–828.
   PubMed Web of Science ®Google Scholar
• Thomassen A, Nielsen TT, Bagger JP, et al. Effects of intravenous glutamate on substrate availability and utilization across the human heart and leg. Metabolism. 1991;40:378–384.
   PubMed Web of Science ®Google Scholar
• Yang WH, Drouin MA, Herbert M, et al. The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol. 1997;99(6):757–762.
   PubMed Web of Science ®Google Scholar
• Geha RS, Beiser A, Ren C, et al. Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate. J Allergy Clin Immunol. 2000;106:973–980.
   PubMed Web of Science ®Google Scholar
• Baad-Hansen L, Cairns BE, Ernberg M, et al. Effect of systemic monosodium glutamate (MSG) on headache and pericranial muscle sensitivity. Cephalalgia. 2010;30:68–76.
   PubMed Web of Science ®Google Scholar
• Shimada A, Cairns BE, Vad N, et al. Headache and mechanical sensitization of human pericranial muscles after repeated intake of monosodium glutamate (MSG). J Headache Pain. 2013;14:2.
   PubMed Web of Science ®Google Scholar
• Shimada A, Baad-Hansen L, Castrillon E, et al. Differential effects of repetitive oral administration of monosodium glutamate on interstitial glutamate concentration and muscle pain sensitivity. Nutrition. 2015;31(2):315–323.
   PubMed Web of Science ®Google Scholar
• Caccia S, Garattini S, Ghezzi P, et al. Plasma and brain levels of glutamate and pyroglutamate after oral monosodium glutamate to rats. Toxicol Lett. 1982;10:169–175.
   PubMed Web of Science ®Google Scholar
• Smith QR. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr. 2000;130:1016S–1022S.
   PubMed Web of Science ®Google Scholar
• Cairns BE, Dong X, Mann MK, et al. Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibers. Pain. 2007;132(1–2):33–41.
   PubMed Web of Science ®Google Scholar
• Cairns BE, Gambarota G, Dunning PS, et al. Activation of periheral excitatory amino acid receptors decreases the duration of local anesthesia. Anesthesiology. 2003;98(2):521–529.
   PubMed Web of Science ®Google Scholar
• Cairns BE, Svensson P, Wang KL, et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2003;90(4):2098–2105.
   PubMed Web of Science ®Google Scholar
• Dong XD, Mann MK, Kumar U, et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience. 2007;146(2):822–832.
   PubMed Web of Science ®Google Scholar
• Wang MW, Kumar U, Dong XD, et al. Expression of NMDA and oestrogen receptors by trigeminal ganglion neurons that innervate the rat temporalis muscle. Chin J Dent Res. 2012;15(2):89–97.
   PubMedGoogle Scholar
• Wong H, Dong XD, Cairns BE. Nerve growth factor alters the sensitivity of rat masseter muscle mechanoreceptors to NMDA receptor activation. J Neurophysiol. 2014;112(9):2275–2282.
   PubMed Web of Science ®Google Scholar
• Fergus A, Lee KS. Regulation of cerebral microvessels by glutamatergic mechanisms. Brain Res. 1997;754(1–2):35–45.
   PubMed Web of Science ®Google Scholar
• Gazerani P, Dong X, Wang M, et al. Sensitization of rat facial cutaneous mechanoreceptors by activation of peripheral N-methyl-d-aspartate receptors. Brain Res. 2010;1319:70–82.
   PubMed Web of Science ®Google Scholar
• Gazerani P, Au S, Dong X, et al. Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis. Pain. 2010;151(3):606–616.
   PubMed Web of Science ®Google Scholar
• Gazerani P, Wang K, Cairns BE, et al. Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women. Pain. 2006;124(3):338–348.
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Alberti A, Floridi A, et al. L-Arginine/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content. J Neurol Sci. 2002;198:9–15.
   PubMed Web of Science ®Google Scholar
• Alam Z, Coombes N, Waring RH, et al. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci. 1998;156:102–106.
   PubMed Web of Science ®Google Scholar
• Cananzi AR, D’Andrea G, Perini F, et al. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 1995;15:132–135.
   PubMed Web of Science ®Google Scholar
• Rajda C, Tajti J, Komoróczy R, et al. Amino acids in the saliva of patients with migraine. Headache. 1999;39:644–649.
   PubMedGoogle Scholar
• Ferrari A, Spaccapelo L, Pinetti D, et al. Effective prophylactic treatments of migraine lower plasma glutamate levels. Cephalalgia. 2009;29(4):423–429.
   PubMed Web of Science ®Google Scholar
• Castrillon EE, Ernberg M, Cairns BE, et al. Interstitial glutamate concentration is elevated in the masseter muscle of myofascial temporomandibular disorder patients. J Orofac Pain. 2010;24:350–360.
   PubMedGoogle Scholar
• Smith JD, Terpening CM, Schmidt SO, et al. Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother. 2001;35:702–706.
   PubMed Web of Science ®Google Scholar
• Vellisca MY, Latorre JI. Monosodium glutamate and aspartame in perceived pain in fibromyalgia. Rheumatol Int. 2014;34(7):1011–1013.
   PubMed Web of Science ®Google Scholar
• Holton KF, Taren DL, Thomson CA, et al. The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms. Clin Exp Rheumatol. 2012;30(6 Suppl 74):10–17.
   PubMed Web of Science ®Google Scholar
• Magnuson BA, Burdock GA, Doull J, et al. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol. 2007;37(8):629–727.
   PubMed Web of Science ®Google Scholar
• Bradstock MK, Serdula MK, Marks JS, et al. Evaluation of reactions to food additives: the aspartame experience. Am J Clin Nutr. 1986;43(3):464–469.
   PubMed Web of Science ®Google Scholar
• Lindseth GN, Coolahan SE, Petros TV, et al. Neurobehavioral effects of aspartame consumption. Res Nurs Health. 2014;37(3):185–193.
   PubMed Web of Science ®Google Scholar
• Schiffman SS, Buckley CE 3rd, Sampson HA, et al. Aspartame and susceptibility to headache. N Engl J Med. 1987;317(19):1181–1185.
   PubMed Web of Science ®Google Scholar
• Van Den Eeden SK, Koepsell TD, Longstreth WT Jr., et al. Aspartame ingestion and headaches: a randomized crossover trial. Neurology. 1994;44(10):1787–1793.
   PubMed Web of Science ®Google Scholar
• Stegink LD, Filer LJ Jr., Baker GL. Effect of aspartame and sucrose loading in glutamate-susceptible subjects. Am J Clin Nutr. 1981;34(9):1899–1905.
   PubMed Web of Science ®Google Scholar
• Wagner K, Vito S, Inceoglu B, et al. The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling. Prostaglandins Other Lipid Mediat. 2014;113–115:2–12.
   PubMed Web of Science ®Google Scholar
• Tokuyama S, Nakamoto K. Unsaturated fatty acids and pain. Biol Pharm Bull. 2011;34(8):1174–1178.
   PubMed Web of Science ®Google Scholar
• Martin HA, Basbaum AI, Goetzl EJ, et al. Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat. J Neurophysiol. 1988;60(2):438–445.
   PubMed Web of Science ®Google Scholar
• Gyires K, Knoll J. Inflammation and writhing syndrome inducing effect of PGE1, PGE2 and the inhibition of these actions. Pol J Pharmacol Pharm. 1975;27(3):257–264.
   PubMedGoogle Scholar
• Taiwo YO, Levine JD. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat. Brain Res. 1990;537(1–2):372–374.
   PubMed Web of Science ®Google Scholar
• DiMartino MJ, Campbell GK Jr., Wolff CE, et al. The pharmacology of arachidonic acid-induced rat paw edema. Agents Actions. 1987;21(3–4):303–305.
   PubMedGoogle Scholar
• Gonzales R, Goldyne ME, Taiwo YO, et al. Production of hyperalgesic prostaglandins by sympathetic postganglionic neurons. J Neurochem. 1989;53(5):1595–1598.
   PubMed Web of Science ®Google Scholar
• Tateishi N, Kaneda Y, Kakutani S, et al. Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis model. Lipids Health Dis. 2015;14:3.
   PubMed Web of Science ®Google Scholar
• Richards DA, Bliss TV, Richards CD. Differential modulation of NMDA-induced calcium transients by arachidonic acid and nitric oxide in cultured hippocampal neurons. Eur J Neurosci. 2003;17(11):2323–2328.
   PubMed Web of Science ®Google Scholar
• Casado M, Ascher P. Opposite modulation of NMDA receptors by lysophospholipids and arachidonic acid: common features with mechanosensitivity. J Physiol. 1998;513(Pt 2):317–330.
   PubMed Web of Science ®Google Scholar
• Miller B, Sarantis M, Traynelis SF, et al. Potentiation of NMDA receptor currents by arachidonic acid. Nature. 1992;355(6362):722–725.
   PubMed Web of Science ®Google Scholar
• Martin YB, Avendano C. Effects of removal of dietary polyunsaturated fatty acids on plasma extravasation and mechanical allodynia in a trigeminal neuropathic pain model. Mol Pain. 2009;5:8.
   PubMed Web of Science ®Google Scholar
• Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int. 2003;23(1):27–36.
   PubMed Web of Science ®Google Scholar
• Ramsden CE, Faurot KR, Zamora D, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013;154(11):2441–2451.
   PubMed Web of Science ®Google Scholar
• Bunner AE, Agarwal U, Gonzales JF, et al. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain. 2014;15:69.
   PubMed Web of Science ®Google Scholar
• Hering-Hanit R, Gadoth N. Caffeine-induced headache in children and adolescents. Cephalalgia. 2003;23(5):332–335.
   PubMed Web of Science ®Google Scholar
• Hagen K, Thoresen K, Stovner LJ, et al. High dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study. J Headache Pain. 2009;10(3):153–159.
   PubMed Web of Science ®Google Scholar
• Nehlig A. Effects of coffee/caffeine on brain health and disease: What should I tell my patients? Pract Neurol. 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004;63(11):2022–2027.
   PubMed Web of Science ®Google Scholar
• Couturier EG, Laman DM, Van Duijn MA, et al. Influence of caffeine and caffeine withdrawal on headache and cerebral blood flow velocities. Cephalalgia. 1997;17(3):188–190.
   PubMed Web of Science ®Google Scholar
• Addicott MA, Yang LL, Peiffer AM, et al. The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate? Hum Brain Mapp. 2009;30(10):3102–3114.
   PubMed Web of Science ®Google Scholar
• Shin HJ, Ryu JH, Kim ST, et al. Caffeine-induced inhibition of the activity of glutamate transporter type 3 expressed in Xenopus oocytes. Toxicol Lett. 2013;217(2):143–148.
   PubMed Web of Science ®Google Scholar
• Laursen JC, Cairns BE, Dong XD, et al. Glutamate dysregulation in the trigeminal ganglion: a novel mechanism for peripheral sensitization of the craniofacial region. Neuroscience. 2014;256:23–35.
   PubMed Web of Science ®Google Scholar
• Sjaastad O, Bakketeig LS. Caffeine-withdrawal headache. The Vågå study of headache epidemiology. Cephalalgia. 2004;24(4):241–249.
   PubMed Web of Science ®Google Scholar
• Silverman K, Evans SM, Strain EC, et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med. 1992;327(16):1109–1114.
   PubMed Web of Science ®Google Scholar
• Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl). 2004;176(1):1–29.
   PubMed Web of Science ®Google Scholar
• Glore S, Ricker A. Trigeminal neuralgia: case study of pain cessation with a low-caffeine diet. J Am Diet Assoc. 1991;91(9):1120–1121.
   PubMedGoogle Scholar
• Allen SS, Froberg DG. The effect of decreased caffeine consumption on benign proliferative breast disease: a randomized clinical trial. Surgery. 1987;101(6):720–730.
   PubMed Web of Science ®Google Scholar